Relmada Therapeutics Inc (RLMD)
2.99
0.00 (0.00%)
USD |
NASDAQ |
Jun 27, 16:00
3.00
+0.01
(+0.33%)
After-Hours: 20:00
Relmada Therapeutics Net Income (Annual): -98.79M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.79M |
| December 31, 2022 | -157.04M |
| December 31, 2021 | -125.75M |
| December 31, 2020 | -59.46M |
| December 31, 2019 | -8.196M |
| June 30, 2019 | -17.32M |
| June 30, 2018 | -8.961M |
| Date | Value |
|---|---|
| June 30, 2017 | -6.286M |
| June 30, 2016 | -2.975M |
| June 30, 2015 | -20.80M |
| June 30, 2014 | -21.34M |
| August 31, 2013 | -0.045M |
| August 31, 2012 | -0.0121M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-157.04M
Minimum
2022
-8.196M
Maximum
2019
-77.76M
Average
-79.12M
Median
Net Income (Annual) Benchmarks
| Lipocine Inc | -16.35M |
| FibroGen Inc | -284.23M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -27.54M |
| iBio Inc | -65.01M |